Daniel started his career in the pharmaceutical industry in 1993 with Pharmacia and Upjohn in Lund, Sweden.
He served in the Medical Department in Sweden and Italy working with clinical development in CNS and oncology drug development. After working for several years in the clinical research field, Daniel Spasic recognized the need for a more customer adaptive clinical CRO, one that embraced his values and was more accessible and responsive to the needs of clients.
As a result, in 1996, Daniel founded TFS International. Under his guidance, TFS has become the leading midsized- and top 15 global clinical CRO serving pharmaceutical, biotechnological, medical device and diagnostic companies in their clinical product development process. TFS has locations throughout Europe and North America, and annual revenues exceeding €100 million.
In 2010 Daniel received the Swedish national award as "Man of The Year" from Ernst & Young and in the same year was also awarded the title "Entrepreneur of The Year" by Founders Alliance. Daniel holds a technical degree in chemical engineering.
Daniel is located in the TFS office in Boston, MA, USA.